Integra Lifesciences Holdings Corp
NASDAQ:IART
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Integra Lifesciences Holdings Corp
NASDAQ:IART
|
US |
|
C
|
CDL Hospitality Trusts
OTC:CDHSF
|
SG |
|
C
|
Cubex Tubings Ltd
NSE:CUBEXTUB
|
IN |
|
D
|
Dr Ing hc F Porsche AG
XMUN:P911
|
DE |
|
P
|
Paychex Inc
XETRA:PCX
|
US |
|
Arko Corp.
NASDAQ:ARKO
|
US |
|
R
|
Reckitt Benckiser Group PLC
DUS:3RB
|
UK |
Wall St Price Targets
IART Price Targets Summary
Integra Lifesciences Holdings Corp
According to Wall Street analysts, the average 1-year price target for IART is 17.54 USD with a low forecast of 14.14 USD and a high forecast of 28.35 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IART's stock price target?
Price Target
17.54
USD
According to Wall Street analysts, the average 1-year price target for IART is 17.54 USD with a low forecast of 14.14 USD and a high forecast of 28.35 USD.
What is the Revenue forecast for Integra Lifesciences Holdings Corp?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 4%.
What is the Gross Profit forecast for Integra Lifesciences Holdings Corp?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Integra Lifesciences Holdings Corp?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 24%.
